Crossref
Ximelagatran as a New Oral Anticoagulant for Thrombosis
Seminars in Vascular Medicine · 01.01.2005 · 5 (03) · 223-225
DOI: 10.1055/s-2005-916160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Seminars in Vascular Medicine, erschienen am 01.01.2005. Verfasst von Ola E Dahl und 1 weiteren Autor:innen. Beteiligte Einrichtung: Thrombosis Research Institute, London, United Kingdom.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AnticoagulantsAzetidinesBenzylaminesChemical and Drug Induced Liver InjuryClinical Trials as TopicHumansMyocardial InfarctionThrombinThrombosisVitamin KWarfarin
Substanzen
AnticoagulantsAzetidinesBenzylaminesVitamin KximelagatranWarfarinThrombin
Autor:innen und Institutionen
- Thrombosis Research Institute, London, United Kingdom.
Zitieren
APA
Dahl, O. E., & Michiels, J. J. (2005). Ximelagatran as a New Oral Anticoagulant for Thrombosis. Seminars in Vascular Medicine, 5(03), 223-225. https://doi.org/10.1055/s-2005-916160
Vancouver
Dahl OE, Michiels JJ. Ximelagatran as a New Oral Anticoagulant for Thrombosis. Seminars in Vascular Medicine. 2005;5(03):223-225. doi:10.1055/s-2005-916160
BibTeX
@article{Dahl2005,
author = {Dahl, Ola E and Michiels, Jan Jacques},
title = {Ximelagatran as a New Oral Anticoagulant for Thrombosis},
journal = {Seminars in Vascular Medicine},
year = {2005},
volume = {5},
number = {03},
pages = {223--225},
doi = {10.1055/s-2005-916160}
}
EUVIMED